Results

Total Results: 1,524 records

Showing results for "drugs".

261. What do we know about how evidence of harm and benefit is communicated in other countries? (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_international_king.ppt
     January 01, 2005 - Methods Literature Review Medline--1996-2006 Search Terms: Patient Education Evidence-based Medicine Pharmaceutical … Preparations Consumer Information Products from Other Countries Description Compare characteristics

262. EHC Research Protocol (Amended): Treatments for Acute Episodic Migraine (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-treatments-research-amended-protocol.pdf
     January 09, 2020 - However, simple analgesics including 2 nonsteroidal anti-inflammatory drugs (NSAIDs) used … reason, the American Headache Society has explicitly stated that opioids and butalbital-containing drugs … therapy versus: 1) nonopioid pharmacologic therapy (e.g., acetaminophen, nonsteroidal anti-inflammatory drugs … effectiveness of nonopioid pharmacologic therapy (e.g., acetaminophen, nonsteroidal anti-inflammatory drugs … , topical nonopioid abortive drug, including: • Acetaminophen • Nonsteroidal anti-inflammatory drugs

263. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
     January 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Results The table below lists the four topics for which (1) preliminary phase III data for drugs, at … San Diego (CA): Amylin Pharmaceuticals, Inc.; 2012 Jan 27 [accessed 2014 Apr 10]. [5 p]. … Get drugs straight to the eye. [internet].

264. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … The topic, buprenorphine implant (Probuphine™, Titan Pharmaceuticals, Inc., South San Francisco, CA

265. Research Protocol: Diabetes Medications for Adults With Type 2 Diabetes: An Update Focused on Monotherapy and Add-On Therapy to Metformin (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
     January 01, 2015 - have also emerged since 2010 which may change the balance of benefit and risk attributable to these drugs … In this era of intensive direct-to-consumer marketing of new drugs, clinicians need a trustworthy source … Health and Human Services; 2008 [cited 2014 July 13]; Available from: http://www.fda.gov/downloads/Drugs … Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs … http:www.effectivehealthcare.ahrq.gov http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation

266. Comparative Effectiveness Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
     January 01, 2006 - Pharmacokinetics, Indications and Dosing of Included Drugs Drug and Trade Name (Trade names … provided only for drugs under patent.) … incapaciation and definite hazard to patient's health; adverse events defined according to Compendium of Pharmaceuticals … having a therapeutic effecton the knee joint) no yes Dolorgiet Pharmaceuticals (Germany … Pharmacokinetics, Indications and Dosing of Included Drugs Appendix B.

267. Methods Guide Atkins (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methods_guide_atkins.pdf
     January 01, 2011 - For example, the individual trials of statin drugs to treat high cholesterol each selected specific … and discrete populations, used different drugs, different dosages, and different cointerventions. … differing risks, nationalities, and underlying conditions provides evidence that the benefits of statin drugs … Drugs 2007;67(14):1969-1979. 20. Walker, CF, Kordas K, Stoltzfus, RJ, et al. … Drug class review of Alzheimer’s drugs. Final report. 2006.

268. Methods-Guidance-Applicability Methods (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-applicability_methods.pdf
     January 01, 2011 - For example, the individual trials of statin drugs to treat high cholesterol each selected specific … and discrete populations, used different drugs, different dosages, and different cointerventions. … differing risks, nationalities, and underlying conditions provides evidence that the benefits of statin drugs … Drugs 2007;67(14):1969-1979. 20. Walker, CF, Kordas K, Stoltzfus, RJ, et al. … Drug class review of Alzheimer’s drugs. Final report. 2006.

269. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/pelvic-pain_research-protocol.pdf
     February 16, 2011 - scientific evidence (level A) for using combined oral contraceptives and nonsteroidal anti-inflammatory drugs … Medical therapies • Analgesics o Non-narcotic agents including nonsteroidal anti-inflammatory drugs … Broad searches for grey literature and regulatory information on such commonly used drugs would likely … We consulted the TEP to determine which studies of drugs or devices would be likely to provide relevant … Our research team also thought it important to search for other drugs (e.g., aromatase inhibitors) that

270. Ch 5-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_5-user-guide-to-ocer_130129.pdf
     January 01, 2012 - However, the expected magnitude of confounding by BMI strongly depends on the specific drugs under … for patients treated with the oral dosage form mainly due to the different way of administering the drugs … For example, in a study assessing the risk of cancer in statin use,4 users of glaucoma drugs (like … However, because many treatments, particularly drugs, are approved for and/or clinically used to treat … Adherence to Drugs and Device Failure or Removal Patients who are on medications could have various

271. Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
     March 24, 2017 - Given the extensive detail on harms for these drugs, we were unable to summarize in a row and have … rather than redoing the entire meta-analysis, we chose to do focused meta- analyses just on those drugs … discussion: “In addition, larger, higher-quality studies have almost all been conducted with new drugs … with pharmaceutical company funding, and these were the only drugs with moderate strength of evidence … treatments improved quality of life, studies were short-term with unclear risk of bias, all oral drugs

272. Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
     March 24, 2017 - Given the extensive detail on harms for these drugs, we were unable to summarize in a row and have … rather than redoing the entire meta-analysis, we chose to do focused meta- analyses just on those drugs … discussion: “In addition, larger, higher-quality studies have almost all been conducted with new drugs … with pharmaceutical company funding, and these were the only drugs with moderate strength of evidence … treatments improved quality of life, studies were short-term with unclear risk of bias, all oral drugs

273. Noninvasive Treatments for Low Back Pain: A Summary of the Research for Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-treatment_consumer.pdf
     November 01, 2016 - Pain Type of Medicine About the medicine: Researchers found: NSAIDs (nonsteroidal anti- inflammatory drugs … Type of Medicine About the medicine: Researchers found: NSAIDs (nonsteroidal anti- inflammatory drugs … Possible Side Effects NSAIDs (nonsteroidal anti-inflammatory drugs) – Celecoxib (Celebrex®), diclofenac

274. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Results The table below lists the four topics for which (1) preliminary phase III data for drugs or … interventions in this Executive Summary and report is organized alphabetically by device and then, pharmaceuticals … phentermine- topiramate (Qsymia®, Vivus, Inc., Mountain View, CA) and lorcaserin (Belviq®, Arena Pharmaceuticals

275. Alcohol-Misuse-Drug-Therapy Consumer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_consumer.pdf
     February 01, 2016 - Medicines To Treat Alcohol Use Disorder A Review of the Research for Adults Is This Information Right for Me? Yes, this information is right for you if: � Your doctor* said you have alcohol use disorder and need to stop drinking or cut down the amount you drink. � You have decided to stop or cut down your dri…

276. Alcohol-Misuse-Drug-Therapy Clinician (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
     February 01, 2016 - Pharmacotherapy for Adults With Alcohol Use Disorder (AUD) in Outpatient Settings Focus of This Summary This is a summary of a systematic review evaluating the evidence regarding the efficacy, comparative effectiveness, and adverse effects of medications in adults with alcohol use disorder (AUD). The systematic revi…

277. Disposition of Comments Report for The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_disposition-comments.pdf
     September 29, 2014 - decade ago the FDA established a 12-week duration of observation as a requirement for approval of drugs … behavior in persons with a legitimate (if not always appropriate) need to use the opioid class of drugs … opioid drug abuse and misuse, while simultaneously enabling appropriate access to pain-relieving drugs … Without considering how opioids should be used in the context of other drugs, devices or techniques, … in its class. ii Methadone’s unique properties distinguish it from other opioid drugs.

278. MS Protocol draft_12_12-13 clean[2] (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/multiple-sclerosis_research-protocol.pdf
     December 17, 2013 - Thus, major questions of interest are whether or not disease-modifying MS drugs alter the natural history … evidence for patient values, beliefs, and preferences regarding discontinuation of disease- modifying drugs … KQ2: What are individual values, beliefs, and preferences regarding discontinuing disease-modifying drugs … Since these drugs are intended for long-term use, possibly for decades, we are looking for studies that … FDA-approved disease modifying drugs were only available after 1993.

279. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Results The table below lists the five topics for which (1) preliminary phase III data for drugs, at … San Diego (CA): Amylin Pharmaceuticals, Inc.; 2012 Jan 27 [accessed 2014 Apr 10]. [5 p]. … Med Lett Drugs Ther. 2013 Dec 9;55(1431):97-8. PMID: 24322663. 74. … Drugs. 2013 Feb;73(2):187-93. PMID: 23335133.

280. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Results The table below lists the four topics for which (1) preliminary phase III data for drugs or